Patient Safety: A Nobody’s Concern


Patient Safety: A Nobody’s Concern


AK MOHIUDDIN
Assistant Professor, faculty of Pharmacy, World University of Bangladesh


 International Journal of Hospital Pharmacy

Patient safety is a global concern and is the most important domains of health-care quality. Medical error is a major patient safety concern, causing increase in health-care cost due to mortality, morbidity, or prolonged hospital stay. A definition for patient safety has emerged from the health care quality movement that is equally abstract, with various approaches to the more concrete essential components. Patient safety was defined by the IOM as “the prevention of harm to patients.” Emphasis is placed on the system of care delivery that prevents errors; learns from the errors that do occur; and is built on a culture of safety that involves health care professionals, organizations, and patients. Patient safety culture is a complex phenomenon. Patient safety culture assessments, required by international accreditation organizations, allow healthcare organizations to obtain a clear view of the patient safety aspects requiring urgent attention, identify the strengths and weaknesses of their safety culture, help care giving units identify their existing patient safety problems, and benchmark their scores with other hospitals.


Keywords: Commercialism; Medication Error; Prescription; Nurse; Patient; Healthcare


Free Full-text PDF


How to cite this article:
AK MOHIUDDIN.Patient Safety: A Nobody’s Concern. International Journal of Hospital Pharmacy, 2019,4:22.


References:

1. Gavin Brookes and Kevin Harvey, Opening up the NHS to market, Journal of Language and Politics, 15, 3, (288), (2016).
2. Roy A. Health Care and the Profit Motive. National Affairs · Spring 2010. Available From: https://www.nationalaffairs.com/publications/detail/health-care-and-the-profit-motive
3. Labrie Y. The Positive Role of Profit in the Field of Health Care. Economic Note. Montreal Economic Institute November 2014 Health Care Series. Available From: http://www.iedm.org/files/note1014_en.pdf
4. APhA. The Issue Of Profit In Health Care. Policy Statement Database Jan 01 1997, Policy Number 9716(PP).
5. The IHC Forum. What is health care consumerism? www.theihccforum.com/about-the-forum/. Accessed January 22, 2018.
6. Statista. Total number of retail prescriptions filled annually in the United States from 2013 to 2024 (in billions)*. Pharmaceutical Products & Market. © Statista 2018. Available From: https://www.statista.com/statistics/261303/total-number-of-retail-prescriptions-filled-annually-in-the-us/
7. Bock LW. Mixing herbal and 
prescription meds. Clinical Feature, Clinical Advisor June 13, 2012. Available From: https://www.clinicaladvisor.com/features/mixing-herbal-and-prescription-meds/article/245427/
8. Bhimji SS, Scherbak Y. Medication Errors. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
9. Naunton M, Gardiner HR, Kyle G. Look-alike, sound-alike medication errors: a novel case concerning a Slow-Na, Slow-K prescribing error. Int Med Case Rep J. 2015;8:51-3. Published 2015 Feb 16. doi:10.2147/IMCRJ.S78637
10. Yang P, Chen N, Wang RR, Li L, Jiang SP. Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital. Ther Clin Risk Manag. 2016;12:1517-1524. Published 2016 Oct 12. doi:10.2147/TCRM.S116789
11. de Oliveira AV, Rocha FT, Abreu SR. Acute liver failure and self-medication. Arq Bras Cir Dig. 2014;27(4):294-7.
12. SHAPIRO Law Group. Medication Errors. 30 Years’ Experience Fighting Medical Negligence. Available From: https://www.shapirolawgroup.com/malpractice-medication-errors
13. J.K. Aronson; Medication errors: what they are, how they happen, and how to avoid them, QJM: An International Journal of Medicine, Volume 102, Issue 8, 1 August 2009, Pages 513–521, https://doi.org/10.1093/qjmed/hcp052
14. Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5):e019101. Published 2018 May 5. doi:10.1136/bmjopen-2017-019101
15. Fujita K, Moles RJ, Chen TF. Quality indicators for responsible use of medicines: a systematic review. BMJ Open. 2018;8(7):e020437. Published 2018 Jul 16. doi:10.1136/bmjopen-2017-020437
16. Jessica G. Doctors in US incorrectly prescribe antibiotics in nearly a third of cases The Guardian May, 03 2016
17. Huffpost. UK NHS Medication Errors Raise Fears Thousands Could Be Dying Because Of 237m Mistakes Every Year Some 237 million errors are made annually February 23, 2018
18. Paulsen RA. Taking nurse staffing research to the unit level. Nurs Manage. 2018;49(7):42-48.
19. Fagerström L, Kinnunen M, Saarela J. Nursing workload, patient safety incidents and mortality: an observational study from Finland. BMJ Open. 2018;8(4):e016367. Published 2018 Apr 24. doi:10.1136/bmjopen-2017-016367
20. Sharew NT, Bizuneh HT, Assefa HK, Habtewold TD. Investigating admitted patients’ satisfaction with nursing care at Debre Berhan Referral Hospital in Ethiopia: a cross-sectional study. BMJ Open. 2018;8(5):e021107. Published 2018 May 17. doi:10.1136/bmjopen-2017-021107
21. Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q 2005;83:457–502. doi:10.1111/j.1468-0009.2005.00409.x
22. Wilson A, McDonald P, Hayes L, et al. Longer booking intervals in general practice: effects on doctors’ stress and arousal. Br J Gen Pract 1991;41:184–7.
23. Kringos D, Boerma W, Bourgueil Y, et al. The strength of primary care in Europe: an international comparative study. Br J Gen Pract 2013;63:742–50. doi:10.3399/bjgp13X674422
24. Lemon TI, Smith RH. Consultation Content not Consultation Length Improves Patient Satisfaction. J Family Med Prim Care. 2014;3(4):333-9.
25. Ahmad BA, Khairatul K, Farnaza A. An assessment of patient waiting and consultation time in a primary healthcare clinic. Malays Fam Physician. 2017;12(1):14-21. Published 2017 Apr 30.
26. NAMCS/NHAMCS – About the Ambulatory Health Care Surveys. https://www.cdc.gov/nchs/ahcd/index.htm (accessed 6 July 2017).
27. Stewart M, Brown JB, Weston WW. Patient-Centred Interviewing Part III: Five Provocative Questions. Can Fam physician Médecin Fam Can 1989;35:159–61.
28. Australian GP Statistics and Classification Centre. General practice activity in Australia 2006–07, 2006
29. Fry J. Hong Kong: Need for improvement in primary care. Lancet 1990;336:558 doi:10.1016/0140-6736(90)92104-P
30. Afghanistan Medicine Use Study: A Survey of 28 Health Facilities in 5 Provinces, 2009.
31. Jin G, Zhao Y, Chen C, et al. The length and content of general practice consultation in two Urban districts of Beijing: a preliminary observation study. PLoS One 2015;10:e0135121 doi:10.1371/journal.pone.0135121 [PMC free article] [PubMed] [Ref list]
32. Sarwal R. Reforming Central Government Health Scheme into a ‘Universal Health Coverage’model. Natl Med J INDIA 2015.
33. Guyon AB, Barman A, Ahmed JU, et al. A baseline survey on use of drugs at the primary health care level in Bangladesh *. Bull World Health Organ 1994;72:265–71.
34. Shen Y, Lee LH. Improving the wait time to consultation at the emergency department. BMJ Open Qual. 2018;7(1):e000131. Published 2018 Jan 3. doi:10.1136/bmjoq-2017-000131
35. Li L, Georgiou A, Vecellio E, Eigenstetter A, Toouli G, Wilson R. et al. The Effect of Laboratory Testing on Emergency Department Length of Stay: A Multihospital Longitudinal Study Applying a Cross-classified Random-effect Modeling Approach. Acad Emerg Med. 2015;22(1):38–46.
36. Howanitz P, Steindel S, Cembrowski G, Long T. Emergency department stat test turnaround times A College of American Pathologists’ Q-Probes study for potassium and hemoglobin. Arch Pathol Lab Med. 1992;116:122–8.
37. Fazl Hashemi SME, Sarabi Asiabar A, Rezapour A, Azami-Aghdash S, Hosseini Amnab H, Mirabedini SA. Patient waiting time in hospital emergency departments of Iran: A systematic review and meta-analysis. Med J Islam Repub Iran. 2017;31:79. Published 2017 Dec 14. doi:10.14196/mjiri.31.79
38. Erenler AK, Akbulut S, Guzel M, et al. Reasons for Overcrowding in the Emergency Department: Experiences and Suggestions of an Education and Research Hospital. Turk J Emerg Med. 2016;14(2):59-63. Published 2016 Feb 26. doi:10.5505/1304.7361.2014.48802
39. Grosgurin O, Cramer B, Schaller M, Sarasin FP, Rutschmann OT. Patients leaving the emergency department without being seen by a physician: a retrospective database analysis. Swiss Med Wkly. 2013 Dec 6;143:w13889. doi: 10.4414/smw.2013.13889. eCollection 2013. PubMed PMID: 24317804.
40. World Health Organization. Health workforce 2030: towards a global strategy on human resources for health, 2015; Available from: http://www.who.int/hrh/documents/15-295Strategy_Report- 04_24_2015.pdf?ua_1.
41. Institute of Medicine (US) National Cancer Policy Forum. Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century: Workshop Summary. Washington (DC): National Academies Press (US); 2009. Supply and Demand in the Health Care Workforce.
42. Singh S, Badaya S. Health care in rural India: A lack between need and feed. South Asian J Cancer. 2014;3(2):143-4.
43. Tiwari R, Negandhi H, Zodpey SP. Health Management Workforce for India in 2030. Front Public Health. 2018;6:227. Published 2018 Aug 20. doi:10.3389/fpubh.2018.00227
44. Rao S. With 1:921, India has healthy doctor-patient ratio. The Times of India Apr 3, 2018
45. World Health Organization . Working together for health. The World Health Report 2006. Geneva: World Health Organization; 2006.
46. Joarder T, Rawal LB, Ahmed SM, Uddin A, Evans TG. Retaining Doctors in Rural Bangladesh: A Policy Analysis. Int J Health Policy Manag. 2018;7(9):847-858. Published 2018 May 5. doi:10.15171/ijhpm.2018.37
47. McBride A, Holle LM, Westendorf C, et al. National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm. 2013;70:609–617.
48. Mendez MN, Gibbs L, Jacobs RA, et al. Impact of a pipercillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006;26:61–67.
49. Pluss-Suard C, Pannatier A, Ruffieux C, et al. Changes in the use of broad-spectrum antibiotics after cefepime shortage: A time series analysis. Antimicrob Agents Chemother. 2012;56:989–994.
50. Hall R, Bryson GL, Flowerdew G, et al. Drug shortages in Canadian anesthesia: A national survey. Can J Anaesth. 2013;60:539–551.
51. Baumer AM, Clark AM, Witmer DR, et al. National survey of the impact of drug shortages in acute care hospitals. Am J Health Syst Pharm. 2004;61:2015–2022.
52. Caulder CR, Mehta B, Bookstaver PB, Sims LD, Stevenson B. Impact of Drug Shortages on Health System Pharmacies in the Southeastern United States. Hosp Pharm. 2015;50(4):279-86.
53. Stavropoulou C, Doherty C, Tosey P. How Effective Are Incident-Reporting Systems for Improving Patient Safety? A Systematic Literature Review. Milbank Q. 2015;93(4):826-66.
54. Pham JC, Girard T, Pronovost PJ. What to do with healthcare incident reporting systems. J Public Health Res. 2013;2(3):e27. Published 2013 Dec 1. doi:10.4081/jphr.2013.e27
55. Ramírez E, Martín A, Villán Y, et al. Effectiveness and limitations of an incident-reporting system analyzed by local clinical safety leaders in a tertiary hospital: Prospective evaluation through real-time observations of patient safety incidents. Medicine (Baltimore). 2018;97(38):e12509.
56. Klemp K, Zwart D, Hansen J, et al. A safety incident reporting system for primary care. A systematic literature review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care. Eur J Gen Pract. 2015;21 Suppl(sup1):39-44.
57. Anja H. Brunsveld-Reinders, M. Sesmu Arbous, Rien De Vos, Evert De Jonge; Incident and error reporting systems in intensive care: a systematic review of the literature, International Journal for Quality in Health Care, Volume 28, Issue 1, 1 February 2016, Pages 2–13, https://doi.org/10.1093/intqhc/mzv100
58. National Rural Hospital Association. Medicare cuts hurt rural America. www.ruralhealthweb.org/advocate/medicare-cuts-hurt-rural. Accessed September 7, 2017
59. Liu Y, Zhong L, Yuan S, van de Klundert J. Why patients prefer high-level healthcare facilities: a qualitative study using focus groups in rural and urban China. BMJ Glob Health. 2018;3(5):e000854. Published 2018 Sep 19. doi:10.1136/bmjgh-2018-000854
60. Barik D, Thorat A. Issues of Unequal Access to Public Health in India. Front Public Health. 2015;3:245. Published 2015 Oct 27. doi:10.3389/fpubh.2015.00245
61. World Health Organization. World Health Statistics 2016: Monitoring Health for the Sustainable Development Goals (SDGs) World Health Organization, 2016. [Ref list]
62. Alaei K, Sarwar M, Juan SC, Alaei A. Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan. Hepat Mon. 2016;16(11):e41262. Published 2016 Oct 15. doi:10.5812/hepatmon.41262
63. Frantzeskaki F, Orfanos SE. Treating nosocomial pneumonia: what’s new. ERJ Open Res. 2018;4(2):00058-2018. Published 2018 Jun 26. doi:10.1183/23120541.00058-2018
64. Vallejo-Torres L, Pujol M, Shaw E, et al. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study. BMJ Open. 2018;8(4):e020251. Published 2018 Apr 12. doi:10.1136/bmjopen-2017-020251
65. Revelas A. Healthcare – associated infections: A public health problem. Niger Med J. 2012;53(2):59-64.
66. Express Scripts. Express Scripts 2015 Drug Trend Report. March 2016. Available From: http://lab.express-scripts.com/lab/drug-trend-report/~/media/e2c9d19240e94fcf893b706e13068750.ashx
67. Sun X, Wei J, Yao Y, et al. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China. BMJ Open. 2018;8(10):e023646. Published 2018 Oct 18. doi:10.1136/bmjopen-2018-023646
68. Kwon HY, Kim H, Godman B. Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications. Front Pharmacol. 2018;9:938. Published 2018 Sep 3. doi:10.3389/fphar.2018.00938
69. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007;85(4):279-88.
70. Woods H, Oronsaye E, Bali A, et al. Development of a provisional essential medicines list for children in Canada: consensus process. CMAJ Open. 2018;6(1):E146-E150.
71. Martin AB, Hartman M, Washington B, Catlin A, National Health Expenditure Accounts Team National Health Spending: faster growth in 2015, as coverage expands and utilization increases. Health Aff. 2017;2017(36):166–176. doi: 10.1377/hlthaff.2016.1330.
72. Keehan SP, Stone DA, Poisal JA, Cuckler GA, Sisko AM, Smith SD, et al. National health expenditure projections, 2016–25: price increases, aging push sector to 20% of economy. Health Aff. 2017;36:553–563. doi: 10.1377/hlthaff.2016.1627.
73. Ward JW, Mermin JH. Simple, effective, but out of reach? Public health implications of HCV drugs. N Engl J Med. 2015;373:2678–2680. doi: 10.1056/NEJMe1513245
74. Hirsch BR, Balu S, Schulman KA. The impact of specialty pharmaceuticals as drivers of health care costs. Health Aff. 2014;33:1714–1720. doi: 10.1377/hlthaff.2014.0558.
75. Chhatwal J, Kanwal F, Roberts MSMS, Dunn MAMA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015;162:397–406. doi: 10.7326/M14-1336
76. Kantarjian H, Rajkumar SV. Why are cancer drugs so expensive in the United States, and what are the solutions? Mayo Clin Proc. 2015;90:500–504. doi: 10.1016/j.mayocp.2015.01.014.
77. Vogler S, Paterson KR. can price transparency contribute to more affordable patient access to medicines? Pharmacoecon Open. 2017;1:145–147. doi: 10.1007/s41669-017-0028-1.
78. Weinberg N, Langreth R. Drug costs too high? Fire the middleman. Bloomberg Businessweek. March 3, 2017. Available From: www.bloomberg.com/news/articles/2017-03-03/drug-costs-too-high-fire-the-middleman. Accessed September 10, 2017
79. UNDP India. India ranks 130 on 2018 Human Development Index. Posted on September 14, 2018.
80. Wu N, Lee YC, Shah N, Harrison DJ. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study. Clin Ther. 2014;36:1231–1241, 1241.e1–1241.e3
81. Glover L. Why are biologic drugs so costly? U.S. News & World Report. February 6, 2015. http://health.usnews.com/health-news/health-wellness/articles/2015/02/06/why-are-biologic-drugs-so-costly. Accessed February 17, 2017.
82. Durvasula R, Kelly J, Schleyer A, Anawalt BD, Somani S, Dellit TH. Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System. Am Health Drug Benefits. 2018;11(2):65-73.
83. High levels of antibiotic resistance found worldwide, new data shows. Saudi Med J. 2018;39(4):430–431.
84. Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645-1658. Published 2018 Oct 10. doi:10.2147/IDR.S173867
85. Medina E, Pieper DH. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Curr Top Microbiol Immunol. 2016;398:3-33. doi: 10.1007/82_2016_492. Review. PubMed PMID: 27406189.
86. Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot (Tokyo). 2017 May;70(5):520-526. doi: 10.1038/ja.2017.30. Epub 2017 Mar 1. Review. PubMed PMID: 28246379.
87. Lázár V, Martins A, Spohn R, Daruka L, Grézal G, Fekete G, Számel M, Jangir PK, Kintses B, Csörgő B, Nyerges Á, Györkei Á, Kincses A, Dér A, Walter FR, Deli MA, Urbán E, Hegedűs Z, Olajos G, Méhi O, Bálint B, Nagy I, Martinek TA, Papp B, Pál C. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat Microbiol. 2018 Jun;3(6):718-731. doi: 10.1038/s41564-018-0164-0. Epub 2018 May 24. PubMed PMID: 29795541.
88. Greenwald PW, Estevez RM, Clark S, Stern ME, Rosen T, Flomenbaum N. The ED as the primary source of hospital admission for older (but not younger) adults. Am J Emerg Med. 2016;34:943-947.
89. Morganti-Gonzalez K, Baufman S, Blanchard J, et al. The Evolving Role of Emergency Departments in the United States. RR 280-ACEP. RAND. Available From: http://www.rand.org/pubs/research_reports/RR280.html. Published 2013.
90. Hsia RY, Niedzwiecki M. Avoidable emergency department visits: a starting point. Int J Qual Health Care. 2017 Oct 1;29(5):642-645. doi: 10.1093/intqhc/mzx081. PubMed PMID: 28992158.
91. Solberg LI, Ohnsorg KA, Parker ED, et al. Potentially Preventable Hospital and Emergency Department Events: Lessons from a Large Innovation Project. Perm J. 2018;22:17-102.
92. Dowd B, Karmarker M, Swenson T, et al. Emergency department utilization as a measure of physician performance. Am J Med Qual 2014;29(2):135-43.
93. Enard KR, Ganelin DM. Reducing preventable emergency department utilization and costs by using community health workers as patient navigators. J Healthc Manag 2013;58(6);412-28.
94. Weinick RM, Burns RM, Mehrotra A. How many emergency department visits could be managed at urgent care centers and retail clinics? Health Aff 2010;29(9):1630-6.
95. Committee on Diagnostic Error in Health Care, Board on Health Care Services, Institute of Medicine, The National Academies of Sciences, Engineering, and Medicine; Balogh EP, Miller BT, Ball JR, editors. Improving Diagnosis in Health Care. Washington (DC): National Academies Press (US); 2015 Dec 29. PubMed PMID: 26803862.
96. UPI Trending. Incorrect diagnoses responsible for 80,000 deaths per year. Health News Sept. 20, 2018
97. Newman-Toker DE. A unified conceptual model for diagnostic errors: underdiagnosis, overdiagnosis, and misdiagnosis. Diagnosis (Berl). 2014;1(1):43-48.
98. Wade DT. How often is the diagnosis of the permanent vegetative state incorrect? A review of the evidence. Eur J Neurol. 2018 Apr;25(4):619-625. doi: 10.1111/ene.13572. Epub 2018 Feb 16. Review. PubMed PMID: 29338107.
99. Colomba P, Zizzo C, Alessandro R, et al. Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. Oncotarget. 2018;9(8):7758-7762. Published 2018 Jan 5. doi:10.18632/oncotarget.23970
100. Ford-Jones PC. Misdiagnosis of attention deficit hyperactivity disorder: ‘Normal behaviour’ and relative maturity. Paediatr Child Health. 2015;20(4):200-2.
101. Gaugler JE, Ascher-Svanum H, Roth DL, Fafowora T, Siderowf A, Beach TG. Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database. BMC Geriatr. 2013;13:137. Published 2013 Dec 19. doi:10.1186/1471-2318-13-137
102. Shen H, Zhang L, Xu C, Zhu J, Chen M, Fang Y. Analysis of Misdiagnosis of Bipolar Disorder in An Outpatient Setting. Shanghai Arch Psychiatry. 2018;30(2):93-101.
103. Moldovan D, Bara N, Nădășan V, Gábos G, Mihály E. Consequences of Misdiagnosed and Mismanaged Hereditary Angioedema Laryngeal Attacks: An Overview of Cases from the Romanian Registry. Case Rep Emerg Med. 2018;2018:6363787. Published 2018 Oct 22. doi:10.1155/2018/6363787
104. James KL, Barlow D, McArtney R, Hiom S, Roberts D, Whittlesea C. Incidence, type and causes of dispensing errors: a review of the literature. Int J Pharm Pract. 2009;17: 9–30. doi: 10.1211/ijpp/17.1.0004
105. Galanter WL, Bryson ML, Falck S, Rosenfield R, Laragh M, Shrestha N, et al. Indication alerts intercept drug name confusion errors during computerized entry of medication orders. PLoS One. 2014;9: 3–9. doi: 10.1371/journal.pone.0101977
106. Flynn EA, Barker KN, Carnahan BJ. National observational study of prescription dispensing accuracy and safety in 50 pharmacies. J Am Pharm Assoc. 2003;43: 191–200. doi: 10.1331/108658003321480731
107. Cheung KC, Bouvy ML, De Smet PAGM. Medication errors: The importance of safe dispensing. Br J Clin Pharmacol. 2009;67: 676–680. doi: 10.1111/j.1365-2125.2009.03428.x
108. Cheung K-C, van der Veen W, Bouvy ML, Wensing M, van den Bemt PMLA, de Smet PAGM. Classification of medication incidents associated with information technology. J Am Med Inform Assoc. 2014;21: e63–70. doi: 10.1136/amiajnl-2013-001818
109. Anto B, Barlow D, Oborne CA, Whittlesea C. Incorrect drug selection at the point of dispensing: A study of potential predisposing factors. Int J Pharm Pract. 2011;19: 51–60. doi: 10.1111/j.2042-7174.2010.00072.x
110. Emmerton LM, Rizk MFS. Look-alike and sound-alike medicines: Risks and “solutions”. Int J Clin Pharm. 2012;34: 4–8. doi: 10.1007/s11096-011-9595-x
111. Ostini R, Roughead EE, Kirkpatrick CMJ, Monteith GR, Tett SE. Quality Use of Medicines—Medication safety issues in naming; Look-alike, sound-alike medicine names. Int J Pharm Pract. 2012;20: 349–357. doi: 10.1111/j.2042-7174.2012.00210.x
112. Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016;4(3):36. Published 2016 Jun 29. doi:10.3390/healthcare4030036
113. Rauh S, Arnold D, Braga S, et al. Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions. ESMO Open. 2018;3(5):e000385. Published 2018 Jul 25. doi:10.1136/esmoopen-2018-000385
114. Mehndiratta A, Sharma S, Gupta NP, Sankar MJ, Cluzeau F. Adapting clinical guidelines in India-a pragmatic approach. BMJ. 2017;359:j5147. Published 2017 Nov 17. doi:10.1136/bmj.j5147
115. Sonawane DB, Karvande SS, Cluzeau FA, Chavan SA, Mistry NF. Appraisal of maternity management and family planning guidelines using the agree II instrument in India. Indian J Public Health 2015;59:264-71. doi:10.4103/0019-557X.169651 pmid:26584165
116. Lob-Levyt J. Vaccines for the poor. An interview with Julian Lob-Levyt. Bull World Health Organ. 2008;86(6):427-8.
117. Doherty TM, Connolly MP, Del Giudice G, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289-300.
118. Lorini C, Santomauro F, Donzellini M, et al. Health literacy and vaccination: A systematic review. Hum Vaccin Immunother. 2017;14(2):478-488.
119. Valido EM, Laksanawati IS, Utarini A. Acceptability of the dengue vaccination among parents in urban poor communities of Quezon City, Philippines before and after vaccine suspension. BMC Res Notes. 2018;11(1):661. Published 2018 Sep 10. doi:10.1186/s13104-018-3766-y
120. Thacher T. Olive Healthcare faces legal action over violations Olive Healthcare was found to be manufacturing enclomiphene, a drug that is approved neither in India nor elsewhere. Livemint. Apr 04 2018.
121. Jahan N, Hossain MA, Hossain A, Amran MS. Review on Pharmacovigilance Practice for Safety of Medication System in Bangladesh. Bangladesh Pharmaceutical Journal 20(1): 105-114, 2017
122. Aboneh EA, Stone JA, Lester CA, Chui MA. Evaluation of Patient Safety Culture in Community Pharmacies. J Patient Saf. 2017 Nov 4. doi: 10.1097/PTS.0000000000000245. PubMed PMID: 29112024.
123. Walton M, Woodward H, Van Staalduinen S, et al. The WHO patient safety curriculum guide for medical schools. Qual Saf Health Care. 2010;19(6):542–546.
124. Ensing HT, Vervloet M, van Dooren AA, Bouvy ML, Koster ES. Patient-pharmacist communication during a post-discharge pharmacist home visit. Int J Clin Pharm. 2018;40(3):712-720.
125. Haynes KT, Oberne A, Cawthon C, Kripalani S. Pharmacists’ recommendations to improve care transitions. Ann Pharmacother. 2012;46(9):1152-9.
126. Ismail S, Osman M, Abulezz R, Alhamdan H, Quadri KHM. Pharmacists as Interprofessional Collaborators and Leaders through Clinical Pathways. Pharmacy (Basel). 2018;6(1):24. Published 2018 Mar 16. doi:10.3390/pharmacy6010024
127. Oswald K. Non-adherence: medicine’s weakest link. The Pharmaceutical Journal February 08, 2018.
128. Laven A, Arnet I. How pharmacists can encourage patient adherence to medicines. The Pharmaceutical Journal August 01, 2018.
129. El-Rachidi S, LaRochelle JM, Morgan JA. Pharmacists and Pediatric Medication Adherence: Bridging the Gap. Hosp Pharm. 2017;52(2):124-131.
130. McDonough PR. Identifying and resolving medication nonadherence. APhA PharmacyToday February 2015Volume 21, Issue 2, Page 44.